JOHN FOREYT to Combined Modality Therapy
This is a "connection" page, showing publications JOHN FOREYT has written about Combined Modality Therapy.
Connection Strength
0.553
-
Naltrexone/Bupropion extended release-induced weight loss is independent of nausea in subjects without diabetes. Clin Obes. 2016 Oct; 6(5):305-12.
Score: 0.097
-
A one-year school-based diet/exercise intervention improves non-traditional disease biomarkers in Mexican-American children. Matern Child Nutr. 2013 Oct; 9(4):524-32.
Score: 0.072
-
Does metabolic syndrome mitigate weight loss in overweight Mexican American women treated for 1-year with orlistat and lifestyle modification? Eat Weight Disord. 2006 Mar; 11(1):e35-41.
Score: 0.047
-
Behavioral interventions for obesity. J Am Diet Assoc. 2005 May; 105(5 Suppl 1):S35-43.
Score: 0.044
-
Partial Meal Replacement Plan and Quality of the Diet at 1 Year: Action for Health in Diabetes (Look AHEAD) Trial. J Acad Nutr Diet. 2015 May; 115(5):731-742.
Score: 0.043
-
Weight loss in obese Mexican Americans treated for 1-year with orlistat and lifestyle modification. Int J Obes Relat Metab Disord. 2003 Dec; 27(12):1486-93.
Score: 0.040
-
The long-term effectiveness of a lifestyle intervention in severely obese individuals. Am J Med. 2013 Mar; 126(3):236-42, 242.e1-2.
Score: 0.038
-
Exercise augments the effects of cognitive-behavioral therapy in the treatment of binge eating. Int J Eat Disord. 2002 Mar; 31(2):172-84.
Score: 0.036
-
Nondieting versus dieting treatment for overweight binge-eating women. J Consult Clin Psychol. 1998 Apr; 66(2):363-8.
Score: 0.027
-
An etiologic approach to obesity. Hosp Pract (1995). 1997 Aug 15; 32(8):123-4, 126, 128 passim.
Score: 0.026
-
Comparison of 2-year weight loss trends in behavioral treatments of obesity: diet, exercise, and combination interventions. J Am Diet Assoc. 1996 Apr; 96(4):342-6.
Score: 0.024
-
Evidence for success of behavior modification in weight loss and control. Ann Intern Med. 1993 Oct 01; 119(7 Pt 2):698-701.
Score: 0.020
-
Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity (Silver Spring). 2011 Jan; 19(1):110-20.
Score: 0.016
-
Effectiveness of Medifast supplements combined with obesity pharmacotherapy: a clinical program evaluation. Eat Weight Disord. 2008 Jun; 13(2):95-101.
Score: 0.014
-
Advances in behavioral treatment of obesity. Prog Behav Modif. 1984; 16:231-61.
Score: 0.010